Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Sinn

Showing results (171-180 of 177) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 177 results.
Oncogene|December 20, 2011
Deubiquitination of EGFR by Cezanne-1 contributes to cancer progressionF Pareja, D A Ferraro, C Rubin, et al.
Zentralblatt Fur Gynakologie|December 26, 2001
[Preoperative chemotherapy in primary operable breast cancer with a dose-dense combination of doxorubicin and docetaxel (ADoc) - Experience of the GEPARDO-GABG study group]G von Minckwitz, G Raab, M Schütte, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 2020
Tumor mutational burden and immune infiltration as independent predictors of response to neoadjuvant immune checkpoint inhibition in early TNBC in GeparNuevoT Karn, C Denkert, K E Weber, et al.
Oncogene|March 21, 2017
The branched-chain amino acid transaminase 1 sustains growth of antiestrogen-resistant and ERα-negative breast cancerV Thewes, R Simon, M Hlevnjak, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 8, 2021
Reconstructing tumor history in breast cancer: signatures of mutational processes and response to neoadjuvant chemotherapy<sup>⋆</sup>C Denkert, M Untch, S Benz, et al.
ESMO Open|November 24, 2022
COGNITION: a prospective precision oncology trial for patients with early breast cancer at high risk following neoadjuvant chemotherapyC Pixberg, M Zapatka, M Hlevnjak, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 31, 2020
Prognostic gene expression signature for high-grade serous ovarian cancerJ Millstein, T Budden, E L Goode, et al.
Pageof 18

Showing results (171-180 of 177) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 177 results.
Oncogene|December 20, 2011
Deubiquitination of EGFR by Cezanne-1 contributes to cancer progressionF Pareja, D A Ferraro, C Rubin, et al.
Zentralblatt Fur Gynakologie|December 26, 2001
[Preoperative chemotherapy in primary operable breast cancer with a dose-dense combination of doxorubicin and docetaxel (ADoc) - Experience of the GEPARDO-GABG study group]G von Minckwitz, G Raab, M Schütte, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 2020
Tumor mutational burden and immune infiltration as independent predictors of response to neoadjuvant immune checkpoint inhibition in early TNBC in GeparNuevoT Karn, C Denkert, K E Weber, et al.
Oncogene|March 21, 2017
The branched-chain amino acid transaminase 1 sustains growth of antiestrogen-resistant and ERα-negative breast cancerV Thewes, R Simon, M Hlevnjak, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 8, 2021
Reconstructing tumor history in breast cancer: signatures of mutational processes and response to neoadjuvant chemotherapy<sup>⋆</sup>C Denkert, M Untch, S Benz, et al.
ESMO Open|November 24, 2022
COGNITION: a prospective precision oncology trial for patients with early breast cancer at high risk following neoadjuvant chemotherapyC Pixberg, M Zapatka, M Hlevnjak, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 31, 2020
Prognostic gene expression signature for high-grade serous ovarian cancerJ Millstein, T Budden, E L Goode, et al.
Pageof 18